A clinic in Honduras has been quietly and successfully using an oleander extract to treat patients previously diagnosed with terminal cancer since 2001. Many patients from the United States have made the pilgrimage and returned home cancer free. Patients who were told by their doctors that there was nothing else to do left for Honduras and returned home completely cured or in dramatic remission. And all this for the properties of the simple oleander.

So what is the secret? Well, there are none. The USFDA knows it all, but in deference to our own cancer and pharmaceutical industries, they hold the position that the oleander extract used by this Clinic is “an unproven medicine.” This despite studies around the world, past and present, from multiple sources, clearly showing that the drug routinely induces death in human cancer cells without harming the patient.

The FDA “protects” us from the possible harmful effects of this oleander extract while flatly ignoring the toxicity study conducted on 28 Beagle dogs in Southern Research Institute, Birmingham Alabama. No clinical signs of toxicity were observed in this study. Another lethality assessment in mice, conducted in Southern Research Institute, San Antonio, Texas, showed no pathological signs or ill effects. In April 2000, the FDA approved a study of this drug in patients with advanced solid tumors. The study was conducted under the direction of Dr. Ronald Buckowski at The Cleveland Clinic, in Cleveland Ohio. The summary of their findings states that oleander extract can be safely administered in specific doses, although no dose-limiting toxicities were found.

This drug is far from a recent discovery. As early as the 8th century AD, Arab doctors used an extract of the poisonous Oleander plant to treat cancer. And that is where the problem lies. That’s what gives the FDA the excuse to prevent an effective drug from upsetting the business balance of the orthodox healthcare community. The medicine used in the Honduras Clinic is a Nerium Oleander Extract (NOE) developed by Dr. Huseyin Ozel at the State Hospital near Mugla, Turkey. Dr. Ozel took out a patent on this extract during the 1970s, calling it Anvirzel.

The USFDA is not alone in its enthusiastic obstruction of progress and innovation in healthcare. When Dr. Ozel received his patent from Anvirzel, the total ire of the conventional Turkish medical establishment descended on him. They had him arrested and tried for “charlatanism.”

But all satisfaction would be denied them. Dr. Ozel had been treating terminally ill cancer patients with his oleander extract for some time, bringing many back from the brink of death. Now they went to court with force, testifying vehemently in defense of Dr. Ozel. Dr. Ozel prevailed. And thus Dr. Ozel’s oleander cure for cancer was born. Except the FDA still stubbornly refuses to accept it, and continues to label it “untested.”

This despite tests carried out in Europe during 1986 and 1987, which confirmed the effect of NOE on the immune system and on cancer. Then the studies showed that NOE was at least six times more potent than the most active immune stimulants available commercially. And in 1988, a team of researchers from the Institute of Pharmacology of the University of Munich unsuccessfully attempted to isolate the active components of NOE. Although several compounds were isolated and identified as possibly beneficial to the immune system, nothing definitive emerged. The conclusion was that NOE should be used as is, further defying any attempt to develop a proprietary pharmaceutical product.

Therefore, the FDA should be content to simply block the marketing of NOEs as much as possible. They keep turning to the irrational reason that raw oleander is toxic and insist on proof that NOE is not. Clinical studies and the hundreds of patients who have left death’s door do not fit into this equation. Costly and often pointless “studies” have to be carried out on endless timelines until hopefully the applicant runs out of money. That’s what happened to Dr. Ozel’s pharmaceutical startup. Its FDA phase I trials were conducted with resounding success. Then he ran out of money. It is expected that it will take years to achieve Anvirzelthrough all FDA trials.

Meanwhile, in 2001, another company obtained a patent for Anvirzel in Honduras and treatment has been there since.

Studies continue to confirm that NOE, Anvirzel induces death in human cancer cells, causes apoptosis, and enhances autophagic cell death in pancreatic cancer cells. Oleander has also been shown to enhance the effects of chemotherapy and radiation while reducing their side effects.

If the FDA has its way, we can all get stuck with the standard cut, burn and poison routine imposed on us by the powerful cancer industry and those of us who contract cancer and insist on being cured will be forced to leave the country.